117 related articles for article (PubMed ID: 5468894)
1. Synergistic antitumor effects of an ethylhydrazide derivative of podophyllic acid combined with x-rays.
Goldenberg DM; Ammersdörfer E
Arzneimittelforschung; 1970 Jun; 20(6):789-90. PubMed ID: 5468894
[No Abstract] [Full Text] [Related]
2. [Prevention of experimental arthritis with the cytostatic agent podophyllinic acid ethylhydrazide].
Szántó L; Lörincz G; Gömör B
Arzneimittelforschung; 1968 Jul; 18(7):886-9. PubMed ID: 5756046
[No Abstract] [Full Text] [Related]
3. Effect of podophyllum products S.P.I.&S.P.G. on malignant diseases.
Datta H; Biswas S
Indian J Cancer; 1968 Jun; 5(2):152-9. PubMed ID: 5688054
[No Abstract] [Full Text] [Related]
4. [On the effect of combined therapy with SP-I Sandoz and radiation in experimental sarcoma 37 in mice].
Benz A
Dermatologica; 1968; 136(5):368-82. PubMed ID: 5662281
[No Abstract] [Full Text] [Related]
5. [Cancer of the esophagus: treatment with the cytostatic agents SP-G and SP-I].
Guida Filho B; Mirra AP
Rev Paul Med; 1968 Feb; 72(2):49-54. PubMed ID: 5739063
[No Abstract] [Full Text] [Related]
6. [Synergic action of x-rays and of the ethylhydrazide of podophyllinic acid on a solid isologous tumor of the C3H mouse].
Donner M; Oth D; Du Cluzel O; Burg C
C R Seances Soc Biol Fil; 1967 Jul; 161(2):403-7. PubMed ID: 4229149
[No Abstract] [Full Text] [Related]
7. Analysis of the results of regional chemotherapy for carcinomas of the orofacial region.
Bilder J; Hornová J
Neoplasma; 1970; 17(1):85-92. PubMed ID: 5447247
[No Abstract] [Full Text] [Related]
8. [Chemical constitution and teratogenic effect in rats. 3. N-alkylcarbonhydrazides, hydrazine derivatives].
von Kreybig T; Preussmann R; von Kreybig I
Arzneimittelforschung; 1970 Mar; 20(3):363-7. PubMed ID: 5467510
[No Abstract] [Full Text] [Related]
9. [Clinical studies of the method of application of antineoplastic agents].
Furue H; Nakao I; Hattori T; Yamana T; Kubo A
Gan No Rinsho; 1970 Sep; 16(9):896-909. PubMed ID: 5528959
[No Abstract] [Full Text] [Related]
10. Adjuvant cancer chemotherapy. Development of a dosage schedule for the adjuvant cancer chemotherapy in surgical cases.
Larsen V; Brockner J; Storm O
Acta Chir Scand Suppl; 1965; 343():202-8. PubMed ID: 4158083
[No Abstract] [Full Text] [Related]
11. [Tumor-host relations in the comprehension of chemotherapeutic effects].
Witte S; Goldenberg DM
Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):517-22. PubMed ID: 4180646
[No Abstract] [Full Text] [Related]
12. [Clinical use of podophyllinic acid ethylhydrazide (SP-I) and podophyllotoxin-beta-o-benzyliden-glucoside (SP-G) in malignant urologic tumors].
Aso Y; Hoshi Y; Okada K; Koiso K; Murahashi I
Gan No Rinsho; 1969 May; 15(5):453-7. PubMed ID: 5387577
[No Abstract] [Full Text] [Related]
13. [Observations on patients treated with proresid].
Bogdanowski T; Lobzowski J; Mroczka A
Wiad Lek; 1971 May; 24(9):893-6. PubMed ID: 5579369
[No Abstract] [Full Text] [Related]
14. [The effect of Proresid on the growth and formation of metastases of the RBI-sarcoma in rats].
Svec F; Altaner C
Med Klin; 1968 Dec; 63(52):2119-25. PubMed ID: 5729222
[No Abstract] [Full Text] [Related]
15. [Immunosuppressive agents in multiple sclerosis. Preliminary trials with Proresid].
Danielczyk W
Wien Med Wochenschr; 1968 Nov; 118(44):934-7. PubMed ID: 5710171
[No Abstract] [Full Text] [Related]
16. [Condylomata acuminata and podophyllin].
Cormane RH
Ned Tijdschr Geneeskd; 1968 Dec; 112(51):2305-7. PubMed ID: 5704924
[No Abstract] [Full Text] [Related]
17. [Experimental bases and clinical aspects of the use of 2 antimitotic derivatives of podophyllum].
Fanchamps A
J Med (Oporto); 1965 Nov; 58(191):673-92. PubMed ID: 5215285
[No Abstract] [Full Text] [Related]
18. [Treatment of chronic connective tissue diseases with cytostatics].
Deicher H; Fricke R; Krull P
Minerva Med; 1970 Jul; 61(55):3040-53. PubMed ID: 4987808
[No Abstract] [Full Text] [Related]
19. [Therapeutic trials with cytostatic drugs in osteodystrophia deformans (Paget)].
Jesserer H; Chlud K; Wandner G
Wien Klin Wochenschr; 1967 Feb; 79(8):137-9. PubMed ID: 5593713
[No Abstract] [Full Text] [Related]
20. [Comparative results of massive endoxan stoss therapy and treatment of malignant tumors with proresid].
Gebhardt KH; Becher R
Med Welt; 1967 Jul; 30():1705-7. PubMed ID: 5616405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
